Dupilumab Subcutaneous and NovoLog FlexPen
Determining the interaction of Dupilumab Subcutaneous and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Novolog Injection
- Dupilumab Subcutaneous-NovoLog Mix 70/30
- Dupilumab Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Dupilumab Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Dupilumab Subcutaneous-NovoLog Mix 70/30 FlexPen
- Dupilumab Subcutaneous-NovoLog PenFill
- NovoLog FlexPen-Dupixent
- NovoLog FlexPen-Duplex T Topical
- NovoLog FlexPen-Durachol
- NovoLog FlexPen-Duraclon
- NovoLog FlexPen-Duraclon injection
- NovoLog FlexPen-Duraflu